Selective serotonin reuptake inhibitors vs benzodiazepines
- Antidepressants and benzodiazepines for panic disorder in adults 2016 · Cochrane Headline outcomes onlyno estimate extracted1 study · 146 participantsLow
It is very uncertain whether SSRIs changes number of dropouts due to adverse effects compared with benzodiazepines (very low certainty).
TCAs showed no clear difference in failure to respond compared with SSRI (low certainty).
TCAs showed no clear difference in total number of dropouts compared with SSRI (low certainty).
It is very uncertain whether antidepressants changes total number of dropouts compared with benzodiazepines (very low certainty).
TCAs showed no clear difference in failure to remit compared with SSRI (moderate certainty).
TCAs showed no clear difference in number of dropouts due to adverse effects compared with SSRI (low certainty).
TCA showed no clear difference in failure to respond compared with MAOI (low certainty).
TCA showed no clear difference in total number of dropouts compared with MAOI (moderate certainty).
TCA showed no clear difference in number of dropouts due to adverse events compared with MAOI (low certainty).
SSRIs showed no clear difference in failure to respond compared with MAOIs (moderate certainty).
SSRIs showed no clear difference in total number of dropouts compared with MAOIs (low certainty).
Antidepressants probably leads to higher failure to remit compared with benzodiazepines (moderate certainty).
SSRIs showed no clear difference in failure to remit compared with MAOIs (moderate certainty).
SSRIs showed no clear difference in number of dropouts due to adverse events compared with MAOIs (low certainty).
SSRIs showed no clear difference in failure to respond compared with SNRIs (high certainty).